Key facts
- This page summarizes Eyal Shamir's Form 4 filing for IceCure Medical Ltd. (ICCM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Nov 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents 404,901 restricted share units ("RSUs") granted on August 11, 2026, 25% of which vest on August 11, 2027 and the remaining 75% of which vest in twelve equal quarterly installments of 6.25% thereafter.
Footnote F2
Represents (i) 2,596 ordinary shares and (ii) 428,685 RSUs (including the RSUs described in Footnote 1 above), of which 9,862 have vested and 418,823 remain unvested as of November 2, 2026. The holdings in clauses (i) and (ii) have been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.